Search Results

, patients will continue to decline chemotherapy. Shared decision-making and patient autonomy remain extremely important aspects of care. Collaborating with the patient and her family to discuss chemotherapy and options or alternatives is essential to this

for adverse effects, (3) reduce stress stemming from the patient–caregiver relationship, and (4) support patients and caregivers in shared decision-making by enabling risks and benefits to be discussed and patient values to be incorporated into

Charting an even-handed, evidence-based path between the 2 extremes involves tailoring early detection efforts toward screening of younger populations and developing more stringent biopsy criteria. Informed and Shared Decision-Making Screening

usage of complementary and alternative medicine . J Cancer Res Clin Oncol 2013 ; 139 : 1515 – 1522 . 3. Thiel FC Schrauder MG Fasching PA . Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by

other stakeholders involved in the treatment decision-making process, as a means to initiate a discussion of value between a provider and patient. Together, the 5 measures encourage shared decision-making based on a patient's individual values. NCCN

when they are trying to complete diagnostic tests and make decisions about a treatment plan. The IOM report details many of the challenges inherent in effective patient-centered communication and shared decision-making, focusing Figure 1 A model

in shared decision-making.” He said the NCCN Evidence Blocks are not prescriptive, but they are a starting point for a productive conversation between patient and physician. Available for 10 Tumor Sites Each evidence block is compiled from

role in shared decision-making, ensuring their treatment plan is truly patient-centered.” “The NCCN Guidelines for Patients: Prostate Cancer outlines essential information about diagnosis and treatment in a comprehensible format. It serves as a

, but shared-decision making could mitigate the impact,” she said. “In the metastatic setting, however, recognition of patient priorities considering treatment and contextual characteristics, such as efficacy, toxicities, impact on daily life, and

language barriers often face added difficulties when participating in shared decision-making. Some patients face conscious or unconscious biases that can have a big impact on their treatment options. “People always say that ‘cancer doesn't discriminate